A major news story from Sanofi this month is that "The European Medicines Agency has approved Dupixent (dupilumab) to treat ...

Sveltekit starter project created with sveltekit, typescript, tailwindcss, postcss, husky, and storybook. The project has the structure set up for the scaleable web application.

Get detailed information on Dupilumab, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated prescription ...

Elusive or ambiguous language doesn't count. For example, setting a goal of launching a side hustle is weak, whereas setting a goal to be a freelance SEO specialist is much more tangible.

French pharma major Sanofi’s (Euronext: SAN) Dupixent (dupilumab), which notched up sales of 3.5 billion euros ($3.8 billion) in third-quarter 2024, +23.8% year-on-year, has picked up yet another ...

Like all treatments, though, biologics have possible side effects. Some of the more common problems with Dupixent, for example. are: Irritation at the injection site Infection with herpes simplex ...

Here’s how it works. The Surface Pen and Surface Slim Pen 2 are the best options for modern Surface PCs; I've been using the former for years without issue, and the latter adds wireless charging ...

The best examples of NFTs are Beeple’s Everydays, CryptoPunks, Nyan Cat, RTFKT’s Digital Sneakers, Cryptovoxels, Decentraland, Jack Dorsey’s First Tweet, Bored Ape Yacht Club, NBA Top Shot, and Sorare ...

Van Nistelrooy lauded Casemiro for being an ‘example’ in the team. He said (via journalist Steven Railston): “I was delighted for Casemiro – the way he’s been training and helping the te ...

Sanofi (SNY) has released an update. Sanofi’s Dupixent has shown promising results in a Phase 3 trial for treating chronic spontaneous urticaria, significantly reducing symptoms like itch and ...

Revenues climbed 11% to $3.72 billion, driven by growth in Eylea HD sales, profits from blockbuster asthma drug Dupixent and oncology drug Libtayo. The top line beat the Zacks Consensus Estimate ...

Immunology drug Dupixent is seeing very strong ... mass of new antibody-based therapies to support a wide moat. For example, two infectious disease antibody cocktails—Ebola cocktail Inmazeb ...